Concepedia

Brenton Flatt

BF

Statistics

Publications

5

Citations

297

H-Index

5

Active since

1994

Affiliations

Exelixis (United States)(Current)

University of Florida

Brenton Flatt is an author at Exelixis (United States) specializing in medicinal chemistry, chemistry, and organic synthesis.

Publications per year

1994–2014

5

Publications

5

Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)

Brenton Flatt, Richard Martin, Tielin Wang et al. · Journal of Medicinal Chemistry · 2009 · 161 citations · Full text

, , +17

Synthesis, Structure, and Reactivity of a Rhenium Oxo-Vinylalkylidene Complex

Brenton Flatt, Robert H. Grubbs, Rusty L. Blanski et al. · Organometallics · 1994 · 52 citations

, , +11

Liver X Receptor (LXR) partial agonists: Biaryl pyrazoles and imidazoles displaying a preference for LXRβ

Ellen K. Kick, Richard Martin, Yinong Xie et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 42 citations · Full text

, , +8

Syntheses of 2,4‐diaryl‐2,3‐dihydro‐1,5‐benzothiazepines

Alan R. Katritzky, Boris V. Rogovoy, Christophe Chassaing et al. · Journal of Heterocyclic Chemistry · 2000 · 22 citations

, , +7

Syntheses of 2-Alkylamino- and 2-Dialkylamino-4,6-diarylpyridines and 2,4,6-Trisubstituted Pyrimidines Using Solid-Phase-Bound Chalcones

Alan R. Katritzky, L.S. Serdyuk, Christophe Chassaing et al. · Journal of Combinatorial Chemistry · 2000 · 20 citations

, , +12

1–5 of 5